SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000947871-21-000170
Filing Date
2021-02-12
Accepted
2021-02-12 16:44:27
Documents
2
Group Members
ORBIMED CAPITAL GP VI LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 ss192008_sc13ga.htm SC 13G/A 54961
2 ss192008_ex99a.htm EX-99.A 9628
  Complete submission text file 0000947871-21-000170.txt   66120
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Subject) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90577 | Film No.: 21628651
SIC: 2834 Pharmaceutical Preparations